The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
Aclaris Theraputics Inc. (ACRS) COM 00461U105 15,988 634,455 SH   SOLE   634,455 0 0
Aeglea Biotherapeutics Inc. (AGLE) COM 00773J103 13,394 1,691,151 SH   SOLE   1,691,151 0 0
Atreca Inc. (BCEL) CL A COM 04965G109 5,943 387,653 SH   SOLE   387,653 0 0
AVROBIO, Inc. (AVRO) COM 05455M100 12,814 1,009,779 SH   SOLE   1,009,779 0 0
BridgeBio Pharma Inc. (BBIO) COM 10806X102 373,797 6,068,125 SH   SOLE   6,068,125 0 0
Harmony Biosciences Holdings Inc. (HRMY) COM 413197104 27,847 842,815 SH   SOLE   842,815 0 0
Marker Therapeutics, Inc. (MRKR) COM 57055L107 7,040 3,142,857 SH   SOLE   3,142,857 0 0
Nabriva Therapeutics plc (NBRV) SHS G63637113 317 191,028 SH   SOLE   191,028 0 0
Nuvation Bio Inc. (NUVB) COM CL A 67080N101 26,554 2,541,009 SH   SOLE   2,541,009 0 0
ObsEva SA (OBSV) COM H5861P103 4,506 1,386,338 SH   SOLE   1,386,338 0 0
Poseida Therapeutics Inc. (PSTX) COM 73730P108 9,963 1,043,267 SH   SOLE   1,043,267 0 0
Verona Pharma plc (VRNA) SPONSORED ADS 925050106 11,140 1,332,485 SH   SOLE   1,332,485 0 0
Zosano Pharma Corporation (ZSAN) COM NEW 98979H202 3,371 2,718,226 SH   SOLE   2,718,226 0 0
Syndax Pharmaceuticals, Inc. (SNDX) COM 87164F105 22,919 1,025,000 SH   SOLE   1,025,000 0 0
Spruce Biosciences, Inc. (SPRB) COM 85209E109 20,011 1,205,511 SH   SOLE   1,205,511 0 0